Flagship Biosciences Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
83
- Latest Deal Type
-
M&A
Flagship Biosciences General Information
Description
Developer of a spatial biology and biomarker analytics platform designed to improve drug development and diagnostics. The company's technology utilizes patented AI image analysis and computational tissue interpretation to deliver quantitative measurements on every cell, enabling customers to identify missed biomarkers, stratify patients for clinical trials, and accelerate the development of precision therapeutics through integrated CLIA-certified laboratory services.
Contact Information
Website
www.flagshipbio.com(Operating Subsidiary)
Corporate Office
- 11800 Ridge Parkway
- Suite 450
- Broomfield, CO 80021
- United States
Corporate Office
- 11800 Ridge Parkway
- Suite 450
- Broomfield, CO 80021
- United States
Flagship Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 06-Oct-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 18-Feb-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B1) | 31-Aug-2022 | Completed | Generating Revenue | |||
| 2. Debt - PPP | 14-Apr-2020 | $614K | $3.5M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 09-Jul-2018 | $3.5M | $3.5M | Completed | Generating Revenue |
Flagship Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-2 | 4,278,829 | $0.000100 | 6% | $0.72 | $0.72 | 1x | $0.72 | 7.57% |
| Series A-1 | 2,256,109 | $0.000100 | 6% | $0.54 | $0.54 | 1x | $0.54 | 3.99% |
Flagship Biosciences Comparisons
Industry
Financing
Details
Flagship Biosciences Competitors (30)
One of Flagship Biosciences’s 30 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Molecular Devices | Corporate Backed or Acquired | San Jose, CA | ||||
| Cytena | Formerly VC-backed | Freiburg, Germany | ||||
| Unchained Labs | Private Equity-Backed | Pleasanton, CA | ||||
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom |
Flagship Biosciences Patents
Flagship Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11568536-B2 | Method for digitally generating scores for multiple diagnostic tests from tissue assayed with a single test | Active | 29-Apr-2020 | ||
| US-20210343004-A1 | Method for digitally generating scores for multiple diagnostic tests from tissue assayed with a single test | Active | 29-Apr-2020 | ||
| US-11449972-B2 | Method for aligning digital images of tissue sections using tissue object correspondences | Active | 14-Oct-2019 | ||
| US-20210110519-A1 | Method for aligning digital images of tissue sections using tissue object correspondences | Active | 14-Oct-2019 | ||
| US-20200342588-A1 | Methods for determining biological relevance of object clustering within tissue samples | Inactive | 26-Apr-2019 | G06T7/0012 |
Flagship Biosciences Signals
Flagship Biosciences Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ampersand Capital Partners | Growth/Expansion | Minority | ||
| BroadOak Capital Partners | Growth/Expansion | Minority | ||
| Research Corporation Technologies | Venture Capital | Minority |
Flagship Biosciences Acquisitions (2)
Flagship Biosciences’s most recent deal was a Merger/Acquisition with Interpace Pharma Solutions. The deal was made on 31-Aug-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Interpace Pharma Solutions | 31-Aug-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| IHCtech | 20-May-2012 | Merger/Acquisition | Laboratory Services (Healthcare) |
Flagship Biosciences FAQs
-
When was Flagship Biosciences founded?
Flagship Biosciences was founded in 2009.
-
Where is Flagship Biosciences headquartered?
Flagship Biosciences is headquartered in Broomfield, CO.
-
What is the size of Flagship Biosciences?
Flagship Biosciences has 83 total employees.
-
What industry is Flagship Biosciences in?
Flagship Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Flagship Biosciences a private or public company?
Flagship Biosciences is a Private company.
-
What is Flagship Biosciences’s current revenue?
The current revenue for Flagship Biosciences is .
-
How much funding has Flagship Biosciences raised over time?
Flagship Biosciences has raised $46.7M.
-
Who are Flagship Biosciences’s investors?
Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies have invested in Flagship Biosciences.
-
Who are Flagship Biosciences’s competitors?
Genomic Expression, Molecular Devices, Cytena, Unchained Labs, and Sphere Fluidics are some of the 30 competitors of Flagship Biosciences.
-
When was Flagship Biosciences acquired?
Flagship Biosciences was acquired on 06-Oct-2026.
-
Who acquired Flagship Biosciences?
Flagship Biosciences was acquired by Lanterne Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process